Centese
Develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | $15.0m | Series B | |
| Total Funding | 000k | ||
Related Content
Centese Inc. is a medical technology company specializing in advanced digital solutions for cardiothoracic surgery. Their flagship product, Thoraguard, revolutionizes post-operative care by providing precise data monitoring and automated chest tube clearance. This innovation aims to enhance clinical decision-making and patient safety, ultimately improving outcomes and reducing costs. Centese serves healthcare providers and hospitals in the cardiothoracic surgery market. Their business model revolves around selling and supporting their digital systems, generating revenue through product sales and service contracts.
Keywords: cardiothoracic surgery, digital intelligence, data monitoring, chest tube clearance, patient safety, clinical decision-making, post-operative care, healthcare providers, medical technology, cost reduction.